Liver Biochem Flashcards
(41 cards)
Liver Circulation
Flow in: 75% by portal v. and 25% by hepatic a.
Flow out: 100% by IVC
Hepatocytes
Metabolic functions of liver (can regenerate)
Endothelial cells
Exchange of material from liver to blood (vice versa) via pores and fenestrations in plasma membrane
Kupffer cells
- Present in lining of sinusoids
- Macrophages that protect liver from microbes, remove dead RBCs, orchestrate immune response
Hepatic stellate cells
Storage of lipids (Vitamin A)
Pit cells
NK cells (lymphocytes)
Cholangiocytes
Line bile ducts, control bile flow rate and bile pH
Isoprenoids
3 Acetyl CoA used to generate one IPP (building blocks of steroids and fat-soluble vitamins)
Sterane ring structure
6 units of IPP form tetracyclic sterane ring (steroid backbone)
Structure of cholesterol (OH group?)
- Allicyclic compound of 4 fused rings
* Hydroxyl group at C3
Cholesterol
- Precursor to bile acids/salts
- Biosynthesis inversely proportional to dietary intake (95% reabsorbed)
Cholesterol synthesis (Phase 1)
- Acetyl CoA – IPP
1. Acetyl CoA – Acetoacetyl CoA
2. Acetoacetyl CoA – HMG CoA (HMG CoA synthase)
3. HMG CoA – Mevalonate (HMG CoA reductase) (*rate-limiting)
4. Mevalonate – IPP
Significance of HMG CoA reductase
- Target of statin drugs
- 8 pass transmembrane protein
- Rate limiting step of cholesterol synthesis
Cholesterol synthesis (Phase 2)
6 IPP – Squalene
Squalene – Lanosterol (inhibited by azoles)
Lanosterol – Cholesterol
Statins
- Strong competitive inhibitors of HMG CoA reductase
- 1000x higher affinity for active site than enzyme
- Also increases SREBP maturation – transcription of LDL receptor and enhance clearance of cholesterol via LDL-receptor mediated endocytosis
Statin side effects
- Myotoxic
- Myopathy d/t depletion of muscle levels of CoQ10 and resultant mitochondrial impairment
Regulation of Cholesterol Synthesis
- Via HMG CoA reductase
- Direct inhibition (via FFAs, bile acids, STATINS)
- Covalent modification (active as dephospho)
- Transcriptional control (binding of TFs to promoter on HMG CoA reductase increases mRNA levels)
- Translational control
- Post-translatonal control
Mechanism of transcriptional control
- HMG CoA reductase w/ sterol regulatory element (SRE) in promoter
- SRE binding proteins bind to SRE
- High [cholesterol] retains SREBP in ER membrane
- Low [cholesterol] triggers translocation of SREBP complex to Golgi
- enzyme is upregulated w/ increased [cholesterol] + biosynthesis of LDL receptor
Antimycotics (cholesterol synthesis inhibitor)
Inhibits 7a hydroxylase
Antiestrogens (cholesterol synthesis inhibitor)
Prevents conversion of desmosterol to cholesterol
Epileptogenic drugs (cholesterol synthesis inhibitor)
Inhibits conversion of squalene to lanosterol (impairs cholesterol trafficking)
Antipsychotic drugs (cholesterol synthesis inhibitor)
Induces dyslipidemia
What enzyme degrades sterane ring of cholesterol?
NO ENZYME
What makes bile acids/salts strong detergents?
- Amphipathic (polar/nonpolar regions)
- Form micelles which increase surface area of lipids to expose them to more lipases